Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block

Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block

Alteplase is a recombinant form of human tissue plasminogen activator (tPA) that converts plasminogen to plasmin essential for fibrinolysis. It is commonly used to treat embolic or thrombotic disorders such as ischemic stroke. Despite its rarity use in ophthalmology, we are reporting the effectivene...

Full description

Saved in:
Bibliographic Details
Main Authors: AR, Siti Noor Atikah, Mohd Khialdin, Safinaz, Mustapha, Mushawiahti, MS, Muhammad Syamil, MZ, Ayesha
Format: Article
Published: Universiti Kebangsaan Malaysia. Faculty of Medicine 2022
Online Access:http://psasir.upm.edu.my/id/eprint/101972/
https://www.researchgate.net/publication/361620632_Intracameral_Recombinant_Tissue_Plasminogen_Activator_rtPA_as_the_Primary_Treatment_for_Secondary_Pupillary_Block
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Putra Malaysia

Internet

http://psasir.upm.edu.my/id/eprint/101972/
https://www.researchgate.net/publication/361620632_Intracameral_Recombinant_Tissue_Plasminogen_Activator_rtPA_as_the_Primary_Treatment_for_Secondary_Pupillary_Block

Similar Items